Amgen (Germany) Today

AMG Stock  EUR 262.35  2.00  0.77%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Amgen is trading at 262.35 as of the 20th of January 2025, a 0.77% up since the beginning of the trading day. The stock's lowest day price was 262.35. Amgen has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 20th of January 2025. Click here to learn more.

Moving against Amgen Stock

  0.89APC Apple IncPairCorr
  0.89APC Apple IncPairCorr
  0.89APC Apple IncPairCorr
  0.89APC Apple IncPairCorr
  0.87AMZ Amazon IncPairCorr
  0.81MSF MicrosoftPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Amgen Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Amgen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Amgen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ChairmanHeinz Schimmelbusch
Business ConcentrationOther, Other (View all Sectors)
Amgen Inc (AMG) is traded on Berlin Exchange in Germany and employs 20 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 105.18 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amgen's market, we take the total number of its shares issued and multiply it by Amgen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Amgen Inc operates under Other sector and is part of Other industry. Amgen generates positive cash flow from operations, but has no cash available
Check Amgen Probability Of Bankruptcy

Amgen Inc Risk Profiles

Although Amgen's alpha and beta are two of the key measurements used to evaluate Amgen's performance over the market, the standard measures of volatility play an important role as well.

Amgen Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Amgen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Analyst Advice Now

   

Analyst Advice

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Module

Amgen Corporate Executives

Elected by the shareholders, the Amgen's board of directors comprises two types of representatives: Amgen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amgen. The board's role is to monitor Amgen's management team and ensure that shareholders' interests are well served. Amgen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amgen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jackson DunckelMember of the Management Board, Chief Financial OfficerProfile

Additional Information and Resources on Investing in Amgen Stock

When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.